Shree Pushkar reports no deviation in utilization of funds from preferential issue of warrants.
Shree Pushkar Chemicals & Fertilisers Limited confirms no deviation in fund utilization from its ₹29.99 crore preferential issue of warrants. As of December 31, 2025, ₹7.50 crore was received. Funds are for investment in a subsidiary for capital expenditure.
This is a standard regulatory disclosure confirming adherence to previous fundraising plans and does not indicate any new material development or change in strategy that would significantly impact the company.
The announcement is a routine compliance filing confirming no deviation in fund utilization, which is a neutral development.
Shree Pushkar Chemicals & Fertilisers Limited has confirmed that there were no deviations or variations in the utilization of funds raised through a preferential issue of fully convertible warrants during the quarter ended December 31, 2025. This statement aligns with the objects outlined in the Explanatory Statement for the Extra Ordinary General Meeting held on December 10, 2025.
The company had raised ₹29.99 crore through this preferential issue, with an allotment date of December 27, 2025. As of December 31, 2025, Shree Pushkar had received ₹7.50 crore, representing 25% of the issue size, as stipulated by SEBI regulations. The remaining 75% will be collected as warrant holders exercise their option to convert the warrants into equity shares within the 18-month tenure.
The funds were originally earmarked for investment in its material wholly-owned subsidiary, Madhya Bharat Phosphate Private Limited, for capital expenditure and expansion of its fertilizer unit in Meghnagar, Jhabua, Madhya Pradesh. The company noted that if the proposed amalgamation of Madhya Bharat Phosphate Private Limited and Kisan Phosphates Private Limited is approved by the National Company Law Tribunal, Mumbai Bench, this object will also encompass Kisan Phosphates Private Limited.
What to do with a filing like this
Shree Pushkar Chemicals & Fertilisers Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shree Pushkar Chemicals & Fertilisers Limited. Read the original for the full detail.